Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

49.8K
Overview
49.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dengue virus introduction and 2025 outlook: scenario-based evaluation of vaccination impact using mathematical modeling.

Cadernos de saude publica·2026
Same author

The health and economic repercussions of declining MMR coverage in the United States.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Real-World Effectiveness of RSVpreF and RSVpreF3 Vaccines in Preventing Hospitalization and Emergency Department Visits Associated With Respiratory Syncytial Virus in Older Adults: A Meta-analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Racial and Ethnic Disparities in Meningococcal Vaccination Coverage and Disease Burden Among U.S. Adolescents.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2025
Same author

School-Level Gaps in MMR Coverage as the Fuel for Measles Outbreaks.

Annals of internal medicine·2025
Same author

A policy roadmap for sustainable mass-testing.

Health affairs scholar·2025
Same journal

Analysis of strength degradation of coal and rock masses and stability of mined areas under long term immersion environment.

PloS one·2026
Same journal

Biogenic Silver-Selenium nanocomposite with anticancer activity and potent efficacy against vancomycin-resistant Staphylococcus aureus.

PloS one·2026
Same journal

Preparation and physicochemical characterization of a biodegradable chitosan/carboxymethyl cellulose hydrogel synthesized in NaOH/urea medium.

PloS one·2026
Same journal

Action-guilt, survivor-guilt, and depression in combat-related PTSD.

PloS one·2026
Same journal

Explainable machine learning for predicting activities of daily living at discharge in stroke patients: A retrospective study using SHAP interpretability.

PloS one·2026
Same journal

Deep learning based two-way feature depiction model for brain tumor detection.

PloS one·2026
See all related articles

Related Experiment Video

Updated: Dec 2, 2025

Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

29.4K

Projecting influenza vaccine effectiveness: A simulation study.

Thomas N Vilches1, Affan Shoukat2, Claudia Pio Ferreira3

  • 1Institute of Mathematics, Statistics and Scientific Computing, University of Campinas, Campinas, SP, Brazil.

Plos One
|November 3, 2020
PubMed
Summary
This summary is machine-generated.

Influenza vaccine effectiveness (VE) declines due to strain mutations and waning immunity. Early vaccination is key to reducing illness, especially in high-risk groups, despite potential VE reductions.

More Related Videos

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.0K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.4K

Related Experiment Videos

Last Updated: Dec 2, 2025

Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

29.4K
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.0K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.4K

Area of Science:

  • Epidemiology
  • Immunology
  • Computational Biology

Background:

  • Influenza vaccine effectiveness (VE) varies seasonally, influenced by viral strain mutations and diminishing immunity post-vaccination.
  • Understanding the interplay between antigenic drift and waning immunity is crucial for accurate VE assessment.

Purpose of the Study:

  • To quantify the relative impact of strain mutations and intraseason waning immunity on influenza VE.
  • To project VE and estimate illness reduction across different vaccine efficacies and epidemic scenarios.

Main Methods:

  • Developed a stochastic, age-structured agent-based simulation model for influenza transmission.
  • Incorporated intraseason waning of immunity and mutation-induced antigenic distance between circulating and vaccine strains.
  • Parameterized the model with published data to project temporal and overall VE.

Main Results:

  • Both temporal and overall VE decreased with increasing attack rates.
  • Lower VE was observed with greater antigenic distance between circulating and vaccine strains.
  • Intraseason waning of immunity led to a more rapid decline in VE and lower overall effectiveness compared to antigenic distance alone.

Conclusions:

  • Vaccination remains vital for reducing influenza burden, even with moderate VE, particularly for high-risk individuals.
  • Optimal vaccination timing should consider both strain evolution and the rate of immunity waning within a season.
  • Early vaccination is a critical strategy for mitigating healthcare utilization and economic impact of seasonal influenza.